Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - hyaluronidase - powder for solution for injection/infusion - 1500 international unit(s) - enzymes; hyaluronidase

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - hyaluronidase - powder for solution for injection/infusion - 1500 international unit(s) - enzymes; hyaluronidase

Malta - English - Medicines Authority

wockhardt uk limited - hyaluronidase - powder for solution for infusion or injection - hyaluronidase 1500 international unit(s)/millilitre - other hematological agents

Malta - English - Medicines Authority

pinewood laboratories ltd ballymacarbry, clonmel, co. tipperary, ireland - hyaluronidase - powder for solution for infusion or injection - hyaluronidase 1500 iu/ml - other hematological agents

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hyaluronidase, quantity: 1500 iu - injection, powder for - excipient ingredients: sodium hydroxide - hypodermoclysis. obstetrics anaesthesia. prevention of postpartum haemorrhage (with ergometrine). as an aid to local anaesthesia in ophthalmology. as an aid to local anaesthesia in fracture reduction. subcutaneous administration of radiopaque substances in pyelography.

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - hyaluronidase - powder for solution for injection/infusion - hyaluronidase 1500 iu - other hematological agents

Namibia - English - Namibia Medicines Regulatory Council

merck-generics rsa (pty) ltd - hyaluronidase - injection - hyaluronidase freeze dried powder for injection 1500 iu/ampoule

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - hyaluronidase - powder for solution for injection - 1500unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - hyaluronidase - powder for solution for injection - 1500unit

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment, but not recommended as primary treatment for this disorder